James J. Mullen, III

James J. Mullen, III

Morrison & Foerster LLP

Contact  |  View Bio  |  RSS

Latest Publications


After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to decide the question, “Are human genes patentable?” The Court’s decision in...more

4/16/2013 - AMP v Myriad DNA Gene Patenting Human Genes Oral Argument Patent-Eligible Subject Matter Patents SCOTUS

Australian Federal Court Upholds Myriad’s Gene Patent

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld Myriad Genetics’ patent on methods for screening for cancer-predisposing...more

2/19/2013 - DNA Gene Patenting Human Genes License Agreements Myriad Patent-Eligible Subject Matter RNA

Myriad Finally Gets Its Day in (the Supreme) Court

INTRODUCTION - The Supreme Court today granted certiorari in Assoc. for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (Myriad), to address the issue of whether human genes are patentable. This...more

12/3/2012 - DNA Human Genes Myriad Patent-Eligible Subject Matter SCOTUS USPTO

3 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.